Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
about
Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancerTumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectinGeneration of immune responses against hepatitis C virus by dendritic cells containing NS5 protein-coated microparticlesTargeting dendritic cells: a promising strategy to improve vaccine effectivenessUse of Cell-Penetrating Peptides in Dendritic Cell-Based VaccinationFunctional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell ResponsesMaterials based tumor immunotherapy vaccinesCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Trial watch: Dendritic cell-based anticancer therapyViral Vaccines and CTL ResponseIn vivo imaging of therapy-induced anti-cancer immune responses in humans.Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapyT-Regulatory Cells and Vaccination "Pay Attention and Do Not Neglect Them": Lessons from HIV and Cancer Vaccine TrialsThe Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating PeptideImmune evasion pathways and the design of dendritic cell-based cancer vaccinesTrial Watch-Immunostimulation with cytokines in cancer therapyTumor cell lysates as immunogenic sources for cancer vaccine designGamma-ray irradiation impairs dendritic cell migration to CCL19 by down-regulation of CCR7 and induction of cell apoptosisPorcine sialoadhesin (CD169/Siglec-1) is an endocytic receptor that allows targeted delivery of toxins and antigens to macrophagesMagnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer ImmunotherapyDendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challenge.A novel method for synthetic vaccine construction based on protein assemblyInfluenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro.Dendritic cell activation by recombinant hemagglutinin proteins of H1N1 and H5N1 influenza A viruses.Theranostic mRNA-loaded microbubbles in the lymphatics of dogs: implications for drug delivery.A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cellsInfluence of dendritic cells on viral pathogenicityProtection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.Efficient induction of a Her2-specific anti-tumor response by dendritic cells pulsed with a Hsp70L1-Her2(341-456) fusion protein.Genome-wide promoter analysis of histone modifications in human monocyte-derived antigen presenting cellsExosomes: A Novel Strategy for Treatment and Prevention of Diseases.Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccinesMucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumorsDistribution and function of macrophage galactose-type C-type lectin 2 (MGL2/CD301b): efficient uptake and presentation of glycosylated antigens by dendritic cellsIn vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity.Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cellsCurrent status of cancer immunotherapyTargeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacyLangerhans cells as targets for immunotherapy against skin cancer.
P2860
Q23918376-58193C9A-74DD-4BC2-92D4-9AEDBB15D19DQ24315864-A5DFE6D4-6D91-48D7-992E-26F7F52B0DA9Q24652467-9207C1B0-4B20-402F-9241-E5168ED93B12Q26746162-F1F3C1CA-8542-43A7-8EC9-2CA5B7BAB262Q26764861-540D842C-778C-454B-9A45-D6D8EA486E07Q26777948-EE146331-372F-493A-9698-EBD504D8289AQ26824135-75D33EB9-170E-465F-A2EF-069EF56D73A0Q26830028-33AFF6AD-C9BE-4263-B96F-BC769193F2B5Q27024047-83147F8C-0964-492A-8AA6-6B167AA5AF89Q27491330-1EBCA964-F7A3-45CD-8A68-7BA0767AFCDCQ27693338-F2B29A6E-D09C-4E94-93D9-0428A6E732A0Q28005535-4226FD5F-E832-4B46-84A3-DF6BFBB3D161Q28074437-AA05E2AB-56ED-43FF-A446-C66D17E38ACFQ28076133-B54A16D0-2114-4E83-A8A5-D4A62DA8F8E7Q28076556-45802736-07DC-465A-9D35-D3769FF16B22Q28078725-D09B7F1D-811C-4744-9871-B925894F5AA5Q28083469-14D2A020-EE30-44AF-9D00-07F579C3FADDQ28386637-D988E69A-389E-48B3-8BBD-6D62242A433CQ28477167-311914AC-CADC-4D18-B912-399899F6044AQ28598312-034EAEFE-BFF4-4706-802D-1A5F22B8029FQ30318566-6636B7E3-8A86-4DA0-A67D-150E194AE465Q30369012-D421B5C2-08BC-4C35-AEDA-0E184AA0D3E0Q30387167-2ACE7974-AAF4-42EE-BD22-CCD44D4F6868Q30393665-7ADEDEDC-4BB3-4138-967C-791F8C5C5598Q30422136-C78C31B1-3BD9-489F-9AA9-E0902B2E2C2FQ33459148-CC8B5099-91E4-4BE4-ABFE-D35762AE2989Q33489629-242BAC03-F13A-4C3D-8D55-3C6ABC2FA156Q33523622-D1F5A1D7-693E-439F-B8D8-A1E10F23C9B3Q33577507-A898B20B-07C1-49E5-B74E-B3921BE7708DQ33750715-37772B46-2520-4A64-BF6F-6881C46AAC11Q33791231-D4D0A542-C1FB-4335-BD93-66F68ACACF7DQ33819656-EAA376E6-A2DE-4AC2-A9F2-16DDC7538217Q33857971-F33A39CD-6CCB-49BE-BF6E-F1B054A96D5DQ33862822-2F8A9808-DD77-4AB8-A424-5E45A36AF23EQ33911282-9EA6A53C-A422-4B23-BB92-9502A4A92A86Q33931622-4F597C8F-0734-42B1-BE56-8244EA369F7FQ33955239-55938077-34BE-4643-BEAA-E0B422438221Q33955720-AECCE93D-35D3-4ED3-91A0-23218E35A67BQ34009407-C02ADBED-4A96-4B13-899E-7CEF5A69F743Q34009436-AAF776D8-6BED-4B62-AEE9-041B61F88A46
P2860
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
@en
type
label
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
@en
prefLabel
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
@en
P356
P1476
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
@en
P2093
I Jolanda M de Vries
Paul J Tacken
P2888
P304
P356
10.1038/NRI2173
P577
2007-10-01T00:00:00Z
P5875
P6179
1009390941